izusek/E+ through Getty Photographs
BeOne Medicines (NASDAQ:ONC) stated on Wednesday that it has obtained approval from the U.S. FDA for a brand new pill model of its remedy, zanubrutinib, a small molecule that inhibits Bruton’s tyrosine kinase.
This approval covers all 5 present indications for
